These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29655960)

  • 1. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
    Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
    Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity.
    Apeland T; Holdaas H; Mansoor MA
    Clin Biochem; 2014 Apr; 47(6):378-82. PubMed ID: 24530370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: A prospective observational study.
    Apeland T; Ushakova A; Mansoor MA; Furriol J; Jonsson G; Marti HP
    Free Radic Biol Med; 2022 Aug; 188():62-70. PubMed ID: 35716825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
    Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
    Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study.
    Apeland T; Mansoor MA; Furriol J; Ushakova A; Jonsson G; Stangeland KW; Marti HP
    Free Radic Biol Med; 2020 Aug; 155():10-18. PubMed ID: 32428564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
    Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
    Ren Fail; 2002 Jul; 24(4):467-75. PubMed ID: 12212826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
    Descamps-Latscha B; Witko-Sarsat V; Nguyen-Khoa T; Nguyen AT; Gausson V; Mothu N; Cardoso C; Noël LH; Guérin AP; London GM; Jungers P
    Kidney Int; 2004 Oct; 66(4):1606-12. PubMed ID: 15458457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma gelsolin levels are decreased and correlate with fibrosis in IgA nephropathy.
    Han C; Zhang L; Zhu X; Tang J; Jin X
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1318-27. PubMed ID: 24047794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
    Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
    Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
    Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy.
    Li Z; Han Q; Ye H; Li J; Wei X; Zhang R; Huang Q; Xu Y; Liu G; Li B; Yang Q
    BMC Nephrol; 2022 Feb; 23(1):78. PubMed ID: 35196994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes.
    Mohammedi K; Bellili-Muñoz N; Driss F; Roussel R; Seta N; Fumeron F; Hadjadj S; Marre M; Velho G
    PLoS One; 2014; 9(5):e96916. PubMed ID: 24819633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study.
    Skoie IM; Dalen I; Omdal R; Jonsson G
    Arch Dermatol Res; 2019 May; 311(4):299-308. PubMed ID: 30830309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of homocysteine on acute ischemic stroke severity: possible role of aminothiols redox status.
    Dong WC; Guo JL; Xu L; Jiang XH; Chang CH; Jiang Y; Zhang YZ
    BMC Neurol; 2024 May; 24(1):175. PubMed ID: 38789928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxidative stress level of IgA nephropathy in children and the effect of early intervention with angiotensin-converting enzyme inhibitors.
    Pei Y; Xu Y; Ruan J; Rong L; Jiang M; Mo Y; Jiang X
    J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316647240. PubMed ID: 27198042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation in IgA nephropathy and the effect of lipo-prostaglandin E1.
    Tian J; Chen JH; Li Q; He Q; Lin WQ
    J Nephrol; 2005; 18(3):243-8. PubMed ID: 16013010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    Garnier AS; Duveau A; Demiselle J; Croué A; Subra JF; Sayegh J; Augusto JF
    PLoS One; 2018; 13(4):e0196101. PubMed ID: 29694420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy.
    Qi YY; Zhou XJ; Cheng FJ; Zhang H
    Dis Markers; 2016; 2016():8123138. PubMed ID: 27563166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Tang C; Chen P; Si FL; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H
    Am J Kidney Dis; 2024 Aug; 84(2):170-178.e1. PubMed ID: 38364955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.